Ключевые слова
allopurinol; febuxostat; Haemophilus influenzae type b vaccine; new drug; SARS-CoV-2 vaccine; vaccine; adverse outcome; Editorial; global health; human; medical liability; needlestick injury; pharmacovigilance; Stevens Johnson syndrome; telemedicine; vaccination reaction; adverse drug reaction; disaster; drug combination; patient safety; side effect